908 organization(s) found
Apmonia
Apmonia Therapeutics is a biotech company committed to develop therapeutic strategies towards multiple types of cancer. We are developing a first-in-class pipeline of next-generation peptide-based therapies targeting the tumor microenvironment to improve the lives of patients with cancer.
Arcus Biosciences
Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer.
ArsenalBio
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Artios Pharma
At Artios, we converge decades of experience from unparalleled DDR insights encapsulating multiple pathways to create breakthrough cancer medicines. We were founded by industry-leading experts having pioneered the field through the invention of the blockbuster PARP inhibitor (now marketed as Lynparza (olaparib) by AstraZeneca) and several successful DDR-based programs. Our team of DDR innovators is leveraging our expertise to fill an industry-leading pipeline.
Artiva Therapeutics
We are deeply committed to making cell therapies broadly accessible to patients with autoimmune disease and cancer.
Asan Medical Center
lnaugurated on June 23, 1989, Asan Medical Center stands as the largest tertiary hospital in Korea. It has been established to embody the founding principles of Asan Foundation founder Chung Ju-yung, ‘helping the underprivileged of our society.’ As a pioneer in healthcare services in Korea, Asan Medical Center has expanded its reach beyond national borders, striving to surpass global standards in medicine.
Ascentage Pharma
Biopharmaceutical company that develops targeted therapies for blood cancers, including chronic myeloid leukemia and CLL.
Asgard Therapeutics
Asgard Therapeutic’s mission is to pioneer direct cell reprogramming for cancer immunotherapy. Our current focus is to develop scalable reprogramming technologies enabling the direct in vivo conversion of cancer cells into professional antigen-presenting dendritic cells, reinstating cancer immunity.
ASGCT (American Society of Gene + Cell Therapy)
The American Society of Gene + Cell Therapy (ASGCT) is the leading professional organization for the advancement of cell and gene therapies. Our members are a diverse community of scientists, physicians, patient advocates, and industry professionals dedicated to turning groundbreaking research into life-changing treatments. Discover who we are, where we came from, and how we are shaping the future of CGT. Our Mission + Vision Mission: To advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. Vision: To be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
ASH
With more than 18,000 members from nearly 100 countries, the American Society of Hematology (ASH) is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
Asher Bio
At Asher Biotherapeutics, we are pioneering a new approach with our cis_targeted immunotherapies. Our immunotherapies selectively activate only the immune cell types that drive the desired therapeutic response. With this innovation, we address an inherent shortcoming of conventional immunotherapies, which indiscriminately act on multiple cell types, resulting in suboptimal efficacy and side effects.
Asian Pediatric Hematology & Oncology Group (APHOG)
The Asian Pediatric Hematology & Oncology Group (APHOG) is a non-political, non-commercial, non-profit organization connecting and helping all pediatric hematology and oncology professionals & patients. in the Asian region. Its goal is to improve the diagnosis and treatment of childhood and AYA cancers.
Asia-Pacific Blood & Marrow Transplant Group (APBMT)
The Asia-Pacific Blood and Marrow Transplantation Group (APBMT) was initiated by transplant physicians from Australia, China, Hong Kong, India, Japan, Republic of Korea, Malaysia and Taiwan in 1990 to share the information regarding hematopoietic stem cell transplantation (HSCT) and promote collaborative basic and clinical studies. They held early APBMT meetings in China and Japan from 1990 to 1994. Since then, the plenary meetings have been held 4 times from 1995 to 2003 and they have been held annually since 2004. As of August 2024, APBMT comprised 23 countries / regions (Australia, Bangladesh, Cambodia, China, Hong Kong, India, Indonesia, Iran, Japan, Korea, Malaysia, Mongolia, Myanmar, Nepal, New Zealand, Pakistan, the Philippines, Singapore, Sri Lanka, Taiwan, Thailand, Uzbekistan, and Vietnam) and are leading a variety of issues regarding HSCT in the Asia-Pacific region.
Asia Pacific Leukemia Consortium (APLC)
The Asia-Pacific Leukemia Consortium (APLC) is a not for profit initiative to improve the management of leukemia and related diseases in the Asia-Pacific (APAC) region. The group aims to address the growing threat of leukemia in APAC region through a collaborative approach to advance disease prevention, patient care, research, clinical trials, and education.
ASNO (Asian Society for Neuro-Oncology)
ASNO (Asian Society for Neuro-Oncology) is organized to promote development of the field of neuro-oncology in the Asian region. The aims of the society are: • to establish and promote high standards for the treatment of patients with cancer affecting the nervous system • to elevate and sustain the education of all involved in neuro-oncology • to encourage mutual fellowship, goodwill, and scientific collaboration among physicians and scientists actively involved in the field of neuro-oncology. The organization has widened its coverage to become a multi-disciplinary group, by welcoming neurosurgeons, radiation oncologist, paediatric and adult oncologists, neurologists, neuropathologists, neuroradiologists, neuroscientists, neuropsychologists, neuropsychiatrists, and allied health professionals.
Asociación Peruana Vidas Sin Cáncer
In Spanish: "Nuestra organización nace en el 2012, impulsada por un grupo de profesionales oncólogos médicos para contribuir a revertir los altos índices de cáncer y los factores de riesgo que predisponen a estos en nuestro País, del mismo modo busca brindar el apoyo al paciente afectado con cáncer y a su familia, a través de una intervención multidisciplinaria e integral con el objetivo de mejorar su calidad de vida. Contamos con un equipo de profesionales y voluntarios comprometidos con el trabajo que realizamos, bajo los principios institucionales y comprometidos con el bienestar del paciente, la familia y la comunidad. Estamos desarrollando nuestra labor en cuatro líneas de acción: promoción de estilos de vida saludable, prevención de enfermedades oncológicas, investigación aplicada en cáncer y mejora de la calidad de vida del paciente afectado de cáncer. Nuestro trabajo busca incidir en autoridades y decisores a favor de los afectados por esta enfermedad, fomentar la autonomía del paciente para promover una sociedad inclusiva; facilitando y promoviendo el desarrollo a través de alianzas y redes."
ASPHO (American Society of Pediatric Hematology/Oncology)
Founded in 1981, the American Society of Pediatric Hematology/Oncology (ASPHO) currently has 2,000 members. ASPHO offers a forum for the exchange of ideas on issues of special interests and concern to people in the specialty, as well as a means for facilitating communication among members. ASPHO is the only professional organization dedicated solely to the professional development and interest of subspecialists in pediatric hematology/oncology. The Society works to actively advance programs and initiatives in professional education, scientific and clinical research, training, and practice issues. ASPHO represents pediatric hematologists/oncologists through active liaisons with numerous professional societies and alliances. Both ASPHO's conference and its journal, Pediatric Blood & Cancer, provide forums for presenting research to colleagues and peers. ASPHO welcomes members' involvement in volunteer activities such as standing committees, task forces, special interest groups, and contributions through member publications and other activities. You have the opportunity to make a difference in the profession through your personal involvement as an ASPHO member.
Association Laurette Fugain
French association that funds leukemia research and promotes donation of blood, platelets and bone marrow.
Association l’Avenir
Childhood-cancer advocacy organisation under international network.